Latest News

The margin story rests on a 98% franchised target, and whether baseline traffic can carry that model through 2028 is still open.

Tens of thousands of cell sites start going up in 2027. How much of that belongs in the stock price now?

IonQ trades at a premium, while SoundHound AI shows a clearer path to profitability.

Intuitive Machines went flat for two years before tripling revenue, while Rocket Lab grew steadily -- but the gap is closing fast.

The chipmaker now expects its revenue to rise over 80% next year. What's a fair price to pay for that?

Korean retail margins are pegged to a mid-2027 recovery, while Taiwan logistics spending is being pulled forward ahead of demand.

Nuclear stocks are in a sell-off, and there might be opportunities for investors at these prices.

Sidekick's cost per conversation fell 28% even as merchant chats rose, a sign the AI assistant may scale without eroding margins.

Sezzle (NASDAQ:SEZL) raised its 2026 outlook after third-quarter revenue rose 42.6% and net income climbed 79.3%, as growth in subscriptions and transaction volume helped drive higher profitability. The company reported revenue of $166.5 million and net income of $47.8 million for the quarter. Adju

Nature's Sunshine Products (NASDAQ:NATR) lowered its full-year 2026 sales and earnings outlook after third-quarter revenue fell 9%, as weakness in China and Taiwan and a slowdown in its North American digital business weighed on results. Net sales for the quarter ended September 30 were $116.6 mill

Sera Prognostics (NASDAQ:SERA) reported a sharp increase in use of its PreTRM preterm birth risk test in the third quarter of 2026, as the company expanded its commercial efforts in Illinois and Florida following Medicaid coverage decisions in both states. Test volume rose 54% from the second quart

QuinStreet (NASDAQ:QNST) reported record revenue and adjusted earnings for its fiscal first quarter of 2027, driven by demand from auto insurers and growth in home services, and raised its outlook for the full year. Revenue increased 46% from a year earlier to $416.7 million in the September quarte

Schrodinger (NASDAQ:SDGR) raised its full-year 2026 outlook for annual contract value and drug discovery revenue after reporting third-quarter growth in both software demand and revenue from its therapeutics collaborations. The company reported total revenue of $64.5 million for the quarter, up 19%

Pattern Group (NASDAQ:PTRN) raised its full-year revenue and adjusted earnings outlook after reporting 38% revenue growth in the third quarter of 2026, as it signed more large brand partners and expanded beyond Amazon. The e-commerce services company reported revenue of $886 million and net income

Qualcomm (NASDAQ:QCOM) reported fiscal fourth-quarter revenue at the high end of its guidance and projected a sharp increase in non-handset business in fiscal 2027, as data center shipments begin to ramp and automotive demand grows. The chipmaker reported non-GAAP revenue of $10.4 billion and non-G

Sinclair (NASDAQ:SBGI) raised its 2026 revenue and earnings outlook after political advertising fueled a 16% increase in third-quarter revenue. The broadcaster also said it would not separate its Ventures portfolio on a standalone basis, though it continues to consider larger broadcast transactions.

The 41% overtime cut in early scheduling tests shows the AI agents are already trimming costs, not just promising to.

New value menus are bringing bargain hunters back to the burger chain's restaurants.

Rising logistics and fuel costs leave shelf-level pricing as the open question, with productivity gains the first line of defense.

With demand for electricity growing at a rapid clip, nuclear power is increasingly important.

Celsius trades at a cheaper valuation but depends heavily on Pepsi for distribution, while Chipotle comes with its own set of risks.

Coupang's cash-rich Korean delivery empire goes head-to-head with Five Below's teen-focused bargain stores, but their valuations tell very different stories.

LeMaitre Vascular (NASDAQ:LMAT) reported 12% organic sales growth in the third quarter of 2026, driven by higher prices and unit volumes, while reiterating its full-year organic growth outlook and lowering its gross margin forecast. CEO George LeMaitre said on the Nov. 4 earnings call that organic

Maravai LifeSciences (NASDAQ:MRVI) raised its 2026 revenue and adjusted EBITDA forecasts after reporting third-quarter sales growth of 10%, driven by demand for mRNA products and continued growth at its Cygnus business. The life sciences company reported revenue of $45.9 million for the quarter. It

Unilever (NYSE:UL) set out a plan to grow annual underlying sales by 4% to 6%, with at least 2% volume growth, as it prepares to focus on beauty, personal care and home care following the planned separation of its Foods business. At its capital markets day in New York, executives said they would co